Pfizer Stock Edges Higher on 2026 Guidance. Expect a Rough Year for Covid Vaccine Sales.

Core Viewpoint - Pfizer anticipates a decline in both revenue and earnings by 2026, indicating potential challenges ahead for the company [1] Financial Projections - The company expects revenue to decrease significantly, reflecting a shift in market dynamics and product demand [1] - Earnings are also projected to fall, suggesting a tightening profit margin in the coming years [1]